Current Problems in Cancer

Papers
(The median citation count of Current Problems in Cancer is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Oncolytic virotherapy: Challenges and solutions59
Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer56
CAR T-cell therapy for B-cell lymphoma43
Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges42
Fibrolamellar carcinoma: An entity all its own30
Chordoma: Current status, problems, and future directions26
Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors26
Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer25
Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae22
Exosomal microRNA panels as biomarkers for hematological malignancies21
Monoclonal antibody based radiopharmaceuticals for imaging and therapy20
Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea18
Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients With MRI-Radiomics: A Systematic Review and Meta-analysis17
Vaginal intraepithelial neoplasia in patients after total hysterectomy17
Risk of lymph node metastasis and prognostic outcome in early gastric cancer patients with mixed histologic type16
Advances in the management of alveolar soft part sarcoma16
Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies16
Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients15
The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study15
Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: A systematic review14
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies – An evidence-based review14
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer14
Tisotumab vedotin in recurrent or metastatic cervical cancer13
Clinical features and prognostic impact of TCF3–PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China13
Disparities in cancer screenings for sexual and gender minorities12
The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer11
Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: A Case Report and Literature Review11
Cancer screenings during the COVID-19 pandemic: An analysis of public interest trends11
Using real world data to support regulatory approval of drugs in rare diseases: A review of opportunities, limitations & a case example10
Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study10
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib10
A targeted approach to phosphoinositide-3-kinase/Akt/mammalian target of rapamycin-induced hyperglycemia10
Conventional cardiac risk factors associated with trastuzumab-induced cardiotoxicity in breast cancer: Systematic review and meta-analysis10
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysis9
Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors9
EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management9
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report9
Chemotherapy and immune check point inhibitors in the management of cervical cancer9
Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literature8
Prognostic value of visceral pleural invasion in the stage pT1-2N2M0 non-small cell lung cancer: A study based on the SEER registry8
Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature8
Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization8
Novel approaches for treatment of endometrial carcinoma7
Severe mental illness in cancer is associated with disparities in psycho-oncological support7
Immunotherapy for lung cancer: Focusing on chimeric antigen receptor (CAR)-T cell therapy7
ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients7
Mucocele-like lesions of the breast - A radiological and clinicopathological analysis7
Cancer during a pandemic: A psychosocial telehealth intervention for young adults7
Social determinants of health, workforce diversity, and financial toxicity: A review of disparities in cancer care7
Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study7
Integration of geriatric assessment into clinical oncology practice: A scoping review7
Selinexor in patients with advanced and recurrent endometrial cancer7
Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients7
Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis7
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC6
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure6
QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer6
Kidney cancer: from genes to therapy6
Seasonal influenza vaccination among cancer patients: A systematic review and meta-analysis of the determinants6
Editorial: Special issue on rare cancers6
Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study6
Recurrence of high-grade vaginal intraepithelial neoplasia after various treatments6
Impact of active tuberculosis on treatment decisions in cancer5
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implications5
Update on the Role of Imaging in Staging of Common Pediatric Abdominal Tumors5
Urachal carcinoma: A case of a rare neoplasm5
The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database5
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?5
Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors5
The ‘comeback’ of Selinexor: From toxic to tolerable5
Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-0035
Gynecologic and Breast Cancers: What's New in Chemoresistance and Chemosensitivity Tests?5
High expression of HOXA5 is associated with poor prognosis in acute myeloid leukemia5
Hyperprogressive disease in patients receiving immune checkpoint inhibitors5
Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis5
Novel prognostic value and potential utility of opioid receptor gene methylation in liquid biopsy for oral cavity cancer5
Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine5
Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?5
Efficacy of trastuzumab deruxtecan in an advanced gastric cancer patient with brain metastasis5
Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer5
Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy5
Delaying adjuvant chemotherapy in advanced gastric cancer patients: Risk factors and its impact on survival outcome5
Clinical study of serum IGFBP7 in predicting lymphatic metastasis in patients with lung adenocarcinoma5
Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapy4
Antibody drug conjugates for patients with breast cancer4
Repurposing Metformin in hematologic tumor: State of art4
Tailoring antiHer2 treatment strategies in breast cancer and beyond4
Cancer during Corona Pandemic: Plight of cancer patients when two evils join hands4
The efficacy evaluation of initial chemotherapy for high-risk gestational trophoblastic neoplasm4
5-Fluorouracil associated neurovascular toxicities4
Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders4
HPV, vaccines, and cervical cancer in a low- and middle-income country4
Patient attendance at molecular tumor board: A new means of shared decision making?4
Emerging new cell therapies/immune therapies in B-cell non-Hodgkin's lymphoma4
Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial)4
Blood-based multi-cancer detection: A state-of-the-art update4
Two-year outcome of concurrent chemoradiation with carboplatin with or without adjuvant carboplatin/fluorouracil in nasopharyngeal cancer: A multicenter randomized trial4
A case of non–small cell lung cancer with danazol-dependent aplastic anemia induced by pembrolizumab4
Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology4
Imaging of breast cancer–beyond the basics4
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature4
Beyond EGFR inhibitors in advanced colorectal cancer: Targeting BRAF and HER24
Altered expression of TGF-β1 and TGF-βR2 in tissue samples compared to blood is associated with food habits and survival in esophageal squamous cell carcinoma4
Progress and challenges in gastroesophageal cancer4
Pattern of tumor invasion, stromal inflammation, angiogenesis and vascular invasion in oral squamous cell carcinoma – A prognostic study4
Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma3
Strategies to reduce health care disparities for sexual and gender minorities3
Patient with EGFR-mutant lung cancer harboring de novo MET amplification successfully treated with gefitinib combined with crizotinib3
18F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastases3
Therapeutic options for contralateral axillary lymph node metastasis in breast cancer3
Emerging immuno-oncology targets in Myelodysplastic Syndromes (MDS)3
Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis3
Identification of genetic biomarkers in urine for early detection of prostate cancer3
Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: a meta-analysis3
Focused review on nutritional status of patients with immunoglobulin light chain amyloidosis3
Mutational profile of hereditary breast and ovarian cancer – Establishing genetic testing guidelines in a developing country3
Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative)3
Effects of nutritional indices and inflammatory parameters on patients received immunotherapy for non-small cell lung cancer3
A nomogram to predict survival and guide individualized induction chemotherapy in T3-4N1M0 nasopharyngeal carcinoma3
Imaging of colon and rectal cancer2
Enhancing skin lesion classification with advanced deep learning ensemble models: a path towards accurate medical diagnostics2
Conditional survival for high-risk early-stage cervical cancer patients with lymph node metastasis after hysterectomy2
Comparative effect of progressive relaxation technique and Benson's technique on anxiety and fatigue in cancer survivors - an experimental study2
Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?2
Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review2
Extraovarian dysgerminoma in a pregnant woman: an extremely rare finding2
Cardiovascular risk and undertreatment of dyslipidemia in lung cancer survivors: A nationwide population-based study2
The development of numerous radiation-induced cavernous malformations in a germ cell tumor patient: A case report2
Neo-adjuvant Vismodegib followed by radiation in locally advanced basal cell carcinoma2
Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases2
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence2
Meaningful engagement of the patient in rare cancer research: sarcoma as an exemplar2
The CC ligand chemokine family members CCL17/CCL22 predict the survival and response to immune checkpoint blockade therapy of patients with head and neck squamous cell carcinoma2
Dural plasmacytoma as the initial presentation of multiple myeloma: A case report and review of the literature2
Primary adrenal diffuse large B cell lymphoma arising within an adrenal myelolipoma: A case report and review of the literature2
Case report: Delayed retinoblastoma relapse in a lymph node after 9 years of complete remission2
Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma2
Examining the Cultural Appropriateness of Advance Care Planning Tools for Adolescents and Young Adults With Cancer: An Example of Cross-Cultural Adaptation of the Voicing My CHOiCES Tool2
Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting2
Optimizing anti–body drug conjugates and radiopharmaceuticals for precision therapy: The next frontier in precision oncology2
Targeting MEK in non-small cell lung cancer2
Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot2
Systemic cystic angiomatosis mimicking metastatic cancer2
Advances in high-risk localized prostate cancer: Staging and management2
Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysis2
Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors2
Creating a culture for change: Lessons from behavioral economics and complexity science to increase serious illness conversations for patients with cancer2
The impact of performing gastric cancer surgery during holiday periods. A population-based study using Dutch upper gastrointestinal cancer audit (DUCA) data2
Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors2
A comparative study of cyclophosphamide, thalidomide and dexamethasone (CTD) versus bortezomib and dexamethasone (BDex) in light-chain amyloidosis2
Nodal recurrences after stereotactic body radiotherapy for early stage non–small-cell lung cancer2
The impact of preoperative immune checkpoint inhibitors on kidney and bladder cancer surgeries: a systematic review☆2
A real-world, population-based study of the trends for incidence and prognosis in high-grade neuroendocrine tumor of cervix2
Perforation of gastric metastasis during chemotherapy with ramucirumab2
Disparities in access to translational research2
Efficacy evaluation of nilotinib treatment in different genomic subtypes of gastrointestinal stromal tumors: A meta-analysis and systematic review1
Clinical oncology research; Review on contemporary methodology standards1
Association between time from diagnosis to treatment and survival of patients with nasopharyngeal carcinoma: A population-based cohort study1
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features1
Peripheral Arterial Disease is Associated With Higher Rates of Hospital Encounters and Mortality in Cancer Patients: A Retrospective Study Conducted at a Tertiary Cancer Center1
MET alterations in advanced non-small cell lung cancer1
Comprehensive Pan-Cancer Analysis of MTF2 Effects on Human Tumors1
Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study1
Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer1
Bronchial artery aneurysms arising from antiangiogenic therapy1
Rare case of intramedullary spinal cord metastasis from nasopharyngeal carcinoma1
Imaging Cancer in Neuroradiology1
The intratumor microbiome varies by geographical location and anatomical site in head and neck squamous cell carcinoma1
Controversies in the treatment of early-stage oral squamous cell carcinoma1
Evaluation and external validation of minor lymphatic pelvic pathway for distant metastases in cervical cancer patients treated with concurrent chemoradiotherapy1
Association of lymph node yield with overall survival in patients with pathologically node negative prostate cancer1
Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-20191
Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC)1
Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic1
Nomogram for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Combining Both Clinicopathological and Imaging Indicators1
Central nervous system metastasis from epithelial ovarian cancer- predictors of outcome1
Contamination of lenalidomide on blister packages after administration and its exposure countermeasures1
Detection of circulating normal and tumor plasma cells in newly diagnosed patients of multiple myeloma and their associations with clinical and laboratory parameters1
Barriers, blocks, and barricades: Disparities to access of palliative care in cancer care1
Innovations for the integration of palliative care for hematologic malignancies1
Brigatinib-induced tuberculosis reactivation: A case report1
Development and validation of nomogram models for predicting postoperative prognosis of early-stage laryngeal squamous cell carcinoma1
Long-term outcomes in patients with central and ultracentral non-small cell lung cancer treated with stereotactic body radiotherapy: single-institution experience1
Bone health in breast cancer1
Bridging the gap: Palliative care integration into survivorship care1
Pituitary enlargement following ipilimumab without long term endocrine dysfunction1
Nasal hemangiopericytoma presenting with oncogenic osteomalasia: A case report and literature review1
Prognostic significance of SIRI in patients with late-stage lung adenocarcinoma receiving EGFR-TKI treatment1
Cellular Therapy Advances in Chronic Lymphocytic Leukemia and Richter's Syndrome1
PEG site metastasis in oropharyngeal squamous cell carcinoma managed with cetuximab and radiotherapy: A case report1
Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK1
Combination of immunotherapy, radiotherapy and denosumab as the best approach even for NSCLC poor prognosis patients: a case report with strong response, prolonged survival and a review of literature1
Integrated dual training in palliative care and oncology1
0.030440092086792